Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2012
11/07/2012CN102766613A Talaromyces emersonii beta-glucanases
11/07/2012CN102766215A Polypeptide with function of synergic targeting treatment of nasopharyngeal carcinoma, nanoparticle carrying the polypeptide and application thereof
11/07/2012CN102766210A Human CTLA-4 antibodies and their uses
11/07/2012CN102766204A Glucagon-like peptide-1 mutant polypeptide, its preparation method and application thereof
11/07/2012CN102766198A Glycopeptide antifungal compound, and preparation method and application thereof
11/07/2012CN102766197A Novel HRP5 analogues and its preparation method
11/07/2012CN102766196A Cation antibacterial peptides, their preparation method and application
11/07/2012CN102766194A Oligopeptide compound with HIV-1 protease inhibitory activity, and preparation method and application thereof
11/07/2012CN102764429A Composition used for increasing regulatory T cells in vivo and use thereof
11/07/2012CN102764428A Application of V-set and transmembrane domain containing 1 (VSTM1) protein in preparation of product for inhibiting leukemia cell proliferation
11/07/2012CN102764427A Application of GPR50 (G protein-coupled receptor 50) as BACE1 (Beta-secretase 1) inhibitor and in preparation of drug for treatment of Alzheimer's disease
11/07/2012CN102764426A Scorpion venom protein polypeptide colon-targeted preparation and preparation method thereof
11/07/2012CN102764425A Peptide selection method
11/07/2012CN102764424A Drug composition of thymopentin composed of five kinds of amino acids and preparation method thereof
11/07/2012CN102764423A Polypeptide drug composition obtained through hydrolysis of animal livers and preparation method thereof
11/07/2012CN102362874B Leech colon targeted oral preparation and preparation method thereof
11/07/2012CN102250213B Matrix metalloproteinase-9 polypeptide inhibitor 3 and application thereof
11/07/2012CN102210668B Application of cantharidin and derivants thereof in preparation of tumor chemotherapy sensitivity enhancing medicine
11/07/2012CN102188367B Insulin glargine injecta and preparation method thereof
11/07/2012CN102133234B Medicines for treating gastric cancer prepared by toad peptide antibiotics
11/07/2012CN102094043B Pig chemotactic factor CXCL12 gene and its uses
11/07/2012CN102091320B Toad peptide antibiotics for preparing medicine for treating liver cancer
11/07/2012CN102091319B Use of toad peptide antibiotic for preparing medicaments for treating herpes zoster
11/07/2012CN102078595B Application of toad peptide antibiotic for preparing medicines for curing tinea manus and pedis
11/07/2012CN102048699B Preparation method for sustained release microsphere of injection triptorelin acetate
11/07/2012CN101955525B Artificial antimicrobial peptide, gene and preparation method thereof
11/07/2012CN101757603B Medicinal composition containing trandolapril taste-masking composition
11/07/2012CN101732695B Compound of brain protein hydrolyzate and maleic acid and method for preparing same
11/07/2012CN101724632B Bullfrog skin active peptide, gene and application thereof in pharmacy
11/07/2012CN101717761B Application of lumbrukinase in treating carotid atherosclerosis
11/07/2012CN101648000B Application of cobrotoxin in preparing medicine for treating arthritis
11/07/2012CN101601859B Application of nattokinase in preparing cerebral protective agent type drugs
11/07/2012CN101501060B Peptides having pharmacological activity for treating disorders associated with altered cell migration, such as cancer
11/07/2012CN101497878B Polypeptide of specific efficient affinity membrane type I substrate metal protease (MT1-MMP), protein and use
11/07/2012CN101491668B Composition with blood-sugar reducing function and preparation method thereof
11/07/2012CN101357946B Cholesterol metabolic regulation protein and use thereof
11/07/2012CN101214373B Open-loop intelligent insulin pump control method
11/07/2012CN101132693B Compositions and methods for the management of hyperproliferative dermatological conditions
11/06/2012US8304526 Antitumor effect of mutant Bik
11/06/2012US8304519 Compositions and methods for modulating dopamine neurotransmission
11/06/2012US8304453 Composition comprising at least one alkanolamide to inhibit migration of langerhans cells and uses therof
11/06/2012US8304393 Epithelial cell growth promoter
11/06/2012US8304392 Pharmaceutical and/or cosmetic composition containing an active principle activator of cytochrome C
11/06/2012US8304391 Peptides that bind to the erythropoietin receptor
11/06/2012US8304390 Administering to a patient taurolidine, taurultam or a mixture as antitumor metastasis agent
11/06/2012US8304389 Methods of inhibiting cell death or inflammation in a mammal by administering a BCL protein
11/06/2012US8304388 Imaging agents
11/06/2012US8304387 Therapeutic formulations of keratinocyte growth factor
11/06/2012US8304386 Long-acting growth hormone and methods of producing same
11/06/2012US8304385 Macrocyclic tetrazolyl hepatitis C serine protease inhibitors
11/06/2012US8304384 Caspase-8 and inflammation, infection and wound healing
11/06/2012US8304383 Atherosclerosis therapy ; circulation of emulsifiers; using bile salts, saponins or detergent surfactant; concurrent administering with statin
11/06/2012US8304382 Anti-inflammatory and anti-allergic cyclic peptides
11/06/2012US8304381 Human prolactin antagonist-angiogenesis inhibitor fusion proteins
11/06/2012US8304234 Compositions and methods for delivery of genetic material
11/06/2012US8304211 Methods of screening molecular libraries and active molecules identified thereby
11/06/2012US8303990 Nanophoresis by placing magnetic nanoparticles conjugated with lipids, proteins, hormones, antioxidants, free radical scavengers into a middle region of an ear; magnetically driving particles through a membrane into the fluid of the inner ear; diagnosis or prophylaxis of ear disorders
11/06/2012US8303986 Hydrophilic/lipophilic polymeric matrix dosage formulation
11/06/2012US8303962 Antibacterial and antifungal peptides
11/06/2012US8303960 Radiolabeled affibody molecules
11/06/2012US8303958 Method of treating immunological disorders by administering truncated BAFF receptors
11/06/2012US8303957 Mutated immunogenic peptides derived from R9M, polynucleotides coding for same and therapeutic uses thereof
11/06/2012US8303951 Neutrokine-alpha antibodies and methods of use thereof
11/06/2012US8303949 Prevention and treatment of oxidative stress disorders by glutathione and phase II detoxification enzymes
11/06/2012US8303945 Mutants of interleukin-1 receptor antagonist
11/06/2012US8303944 Hepatitis C virus inhibitors
11/06/2012CA2594711C Somatostatin analogue formulations
11/06/2012CA2545359C Compositions and methods for regulation of tumor necrosis factor-alpha
11/06/2012CA2534358C Bowman-birk inhibitor compositions for treatment of muscular atrophy and degenerative muscle disease
11/06/2012CA2498143C Antimicrobial composition and method for use
11/06/2012CA2497973C Antibiotic microspheres for treatment of infections and osteomyelitis
11/06/2012CA2493083C Composition for cytocompatible, injectable, self-gelling chitosan solutions for encapsulating and delivering live cells or biologically active factors
11/06/2012CA2489208C Interleukin-6 suppressive agent
11/06/2012CA2419996C Enhanced in vitro synthesis of active proteins containing disulfide bonds
11/06/2012CA2393467C Chordin-like molecules and uses thereof
11/06/2012CA2378751C Stable factor viii compositions
11/06/2012CA2365533C Diagnosis and treatment of neuroectodermal tumors
11/06/2012CA2365532C Arpe-19 as a platform cell line for encapsulated cell-based delivery
11/06/2012CA2305630C Soluble single-chain t-cell receptor proteins
11/02/2012CA2775299A1 Thrombin isolated from blood and blood fractions
11/01/2012WO2012149563A1 Chemical modification of apolipoprotein mimetic peptides for the production of therapeutic agents
11/01/2012WO2012149515A2 Novel vegf mimetic peptide-based scaffolds for therapeutic angiogenesis and methods for their use
11/01/2012WO2012149481A1 Novel peptide inhibitors of serotonin 5-ht2c receptor:pten interaction
11/01/2012WO2012149463A1 Chimeric factor vii molecules with enhanced half life and methods of use
11/01/2012WO2012149451A1 Intravascular delivery of nanoparticle compositions and uses thereof
11/01/2012WO2012149440A2 Therapeutic nuclease compositions and methods
11/01/2012WO2012149439A2 Il4/il13 binding repeat proteins and uses
11/01/2012WO2012149416A2 Human myeloid derived suppressor cell cancer markers
11/01/2012WO2012149389A2 Methods of treating alzheimer's disease, huntington's disease, autism, or other disorders
11/01/2012WO2012149376A2 Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same
11/01/2012WO2012149358A1 Injectable preformed macroscopic 3-dimensional scaffolds for minimally invasive administration
11/01/2012WO2012149285A1 Method for treatment of macular degeneration by modulating p2y12 or p2x7 receptors
11/01/2012WO2012149263A1 Treatment and prevention of gastrointestinal syndrome
11/01/2012WO2012149254A2 Mfg-e8 and uses thereof
11/01/2012WO2012149251A1 Methods and compositions using pde4 inhibitors for the treatment and management of autoimmune and inflammatory diseases
11/01/2012WO2012149111A1 Methods of promoting cns neuronal repair by inhibiting lrp-1
11/01/2012WO2012149024A2 Dna aptamers for promoting remyelination
11/01/2012WO2012149018A1 Mer tyrosine kinase inhibitors and methods of making and using the same
11/01/2012WO2012148943A1 Crystal structures of dolastatin 16, dolamethylleuine and dolaphenvaline, and methods for preparing dolamethylleuine and dolaphenvaline
11/01/2012WO2012148891A1 Peptide-lipid conjugates and uses thereof
1 ... 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 ... 3163